We will always be clear and upfront with you from the moment you come in for your free consultation
The new data suggests the problem may be dose-dependent, meaning higher exposure to semaglutide could significantly increase the risk of optic nerve injury
Hitting a Weight Loss Plateau If the scale has stopped moving while taking semaglutide, you may have run into your first weight loss plateau
Meanwhile, Wegovy and similar medications are structured for chronic weight management, offering differing dosages and clinical support data
Yes, but dose adjustment is required
UnitedHealthcare typically requires BMI 30 kg/m, or BMI 27 kg/m with at least one weight-related comorbidity (hypertension, dyslipidemia, sleep apnea, or cardiovascular disease)